ALEXION PHARMACEUTICALS INC.

In News

Alexion Pharmaceuticals Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Revelio Labs - Apr 08, 2026

AstraZeneca highlights rare diseases in $80bn revenue push - Financial Times

Financial Times - Jul 19, 2026

Xencor to Receive $105 Million From Alexion to Resolve Ultomiris® U.S. Royalty Matter - Business Wire

Business Wire - Jul 29, 2026

Ex-employees get jury trial on ‘age-biased’ rehiring program - masslawyersweekly.com

masslawyersweekly.com - Apr 07, 2026

Alexion, AstraZeneca Rare Disease, enters agreement with Pfizer to acquire a portfolio of preclinical rare disease gene therapies - AstraZeneca

AstraZeneca - Jul 28, 2023

Geographic Atrophy Market to Surge Significantly During the - GlobeNewswire

GlobeNewswire - Dec 01, 2025

INSIGHT: Alexion to Acquire Achillion With Contingent Value Rights - news.bloombergtax.com

news.bloombergtax.com - Nov 22, 2019

Document - SEC.gov

SEC.gov - May 01, 2021

AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trial - biopharmadive.com

biopharmadive.com - Jul 24, 2025

AstraZeneca concludes Alexion acquisition for $39bn - Pharmaceutical Technology

Pharmaceutical Technology - Jul 22, 2021

Alexion Pharmaceuticals Completes Acquisition of Portola Pharmaceuticals - Paul, Weiss

Paul, Weiss - Jul 02, 2020

AstraZeneca closes mega $39B Alexion buyout despite antitrust fears, making a splash in rare diseases - Fierce Pharma

Fierce Pharma - Jul 21, 2021

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment